An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

LMPD Officer Travis Tracy, who serves the city's 3rd Division, needs help after he suffered a sudden heart attack. Now he and ...

A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...

If you are diabetic and find you have trouble avoiding sugary beverages, consider the sweeteners allulose, monk fruit and ...

The long-term risk for heart disease following a COVID infection was true for anyone, even for people who don't have any ...

Broken Heart Syndrome mimics symptoms of a heart attack. It can strike after a stressful event, such as the loss of a loved ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the risk of heart attacks and strokes, according to a study in The Lancet.

This Heart Health Awareness Month, a Temple mother is sharing her story of survival, from an unexpected heart attack to a ...

It blocks receptors for interleukin-6 (IL-6), a signaling protein that tells the immune system to become active after, for example, a heart attack, which dampens the body’s inflammatory response.

Those in the sotagliflozin group experienced a 23% reduction in heart attacks, strokes, and cardiovascular-related deaths compared to the placebo group. “The benefits seen here are distinct from ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

After surviving a widowmaker heart attack, a Rock Hill native and pastor is sharing story to spread awareness of heart ...